BFRI Biofrontera Inc. - Common Stock
NASDAQ · Pharmaceuticals close Oct 2, 2026BFRI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BFRI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| July 5, 2023 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.05 | $-0.11 | 53.3% |
| March 31, 2026 | May 14, 2026 | $-0.37 | $-0.12 | -215.4% |
| Dec. 31, 2025 | $0.48 | $0.20 | 142.8% | |
| Sept. 30, 2025 | $-0.62 | $-0.59 | -4.8% | |
| June 30, 2025 | $-0.57 | $-0.43 | -33.1% | |
| March 31, 2025 | $-0.47 | $-0.22 | -114.3% | |
| Dec. 31, 2024 | $-0.25 | $-0.03 | -880.4% |
Institutional owners (13F) 20 filers · $2.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 (+7 vs prior Q) | 2 (-1 vs prior Q) | 4 (-3 vs prior Q) | 2 (+1 vs prior Q) | +370K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $1,206,088 | 1,275,609 | 45.93% | Shares |
| AIGH Capital Management LLC | $699,585 | 739,910 | 26.64% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $148,921 | 157,505 | 5.67% | Shares |
| CITADEL ADVISORS LLC | $99,222 | 104,941 | 3.78% | Shares |
| JANE STREET GROUP, LLC | $87,932 | 93,000 | 3.35% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $72,513 | 76,689 | 2.76% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $67,525 | 71,380 | 2.57% | Shares |
| VANGUARD GROUP INC | $64,952 | 113,951 | 2.47% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $58,365 | 61,697 | 2.22% | Shares |
| XTX Topco Ltd | $49,066 | 51,894 | 1.87% | Shares |
| NORTHERN TRUST CORP | $29,817 | 31,536 | 1.14% | Shares |
| UBS Group AG | $17,518 | 18,518 | 0.67% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $9,710 | 10,000 | 0.37% | Shares |
| Sanctuary Advisors, LLC | $9,644 | 10,200 | 0.37% | Shares |
| BlackRock, Inc. | $4,370 | 4,622 | 0.17% | Shares |
| Tower Research Capital LLC (TRC) | $314 | 332 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $288 | 305 | 0.01% | Shares |
| HRT FINANCIAL LP | $40 | 43,349 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $9 | 10,022 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Deutsche Balaton Aktiengesellschaft, VV Beteiligungen Aktiengesellschaft, Delphi Unternehmensberatung Aktiengesellschaft, Wilhelm Konrad Thomas Zours, Rolf Birkert, Alexander Link ×2 filings | Sept. 19, 2022 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 11 insiders · 5 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hermann Luebbert | CEO & Chairman | March 5, 2026 M | 290,211 | 0 | 0 | $0 |
| Erica L. Monaco | Chief Executive Officer | May 18, 2023 M | 133,025 | 0 | 0 | $0 |
| Eugene Frederick Leffler | Chief Financial Officer | March 5, 2026 M | 175,000 | 0 | 0 | $0 |
| George Patrick Jones | Chief Commercial Officer | March 4, 2026 A | · | 0 | 0 | $0 |
| Erica F. Gates | Senior Director Finance | May 18, 2022 A | · | 0 | 0 | $0 |
| Heikki Lanckriet | Director | March 4, 2026 A | · | 0 | 0 | $0 |
| Kevin Daniel Weber | Director | March 4, 2026 A | · | 0 | 0 | $0 |
| Beth J. Hoffman | Director | March 4, 2026 A | · | 0 | 0 | $0 |
| John J Borer III | Director | March 4, 2026 A | · | 0 | 0 | $0 |
| Biofrontera AG | Director | Sept. 16, 2025 P | · | 0 | 0 | $0 |
| Loretta M. Wedge | Director | May 18, 2022 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 71,380 SH | Aug. 19, 2026 | Daily |
BFRI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
2 analysts · 2026-09-28Mean target $6.00 +491.1%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BFRI | · | · | · | · | · | · |
| RKTO | · | · | · | · | · | · |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | · |
| CTXR | · | -0.4 | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| KPRX | $7M | -0.7 | · | · | -56.6% | · |
| CALC | · | -3.3 | -29.7% | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.